Research Institute Investigates Possible Image Manipulation in Papers

PubPeer commenters have flagged more than 100 papers from branches of the Council of Scientific & Industrial Research for apparent image duplication and other issues.

Written byShawna Williams
| 1 min read
a magnifying glass

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: © ISTOCK.COM, GOLUBOVY

India’s Council of Scientific & Industrial Research is investigating potential image-manipulation problems flagged by PubPeer commenters in 130 papers from its Indian Institute of Toxicology Research, The Hindu reported last week (June 4). The publication has separately reported PubPeer comments pointing out apparent image manipulation for 31 papers from the CSIR-Indian Institute of Chemical Biology (CSIR-IICB), and 35 from the CSIR-Central Drug Research Institute (CSIR-CDRI).

“CSIR has a zero tolerance policy on the issue of scientific integrity. In the past, such matters have been dealt with very firmly,” CSIR Director-General Shekhar Mande tells The Hindu in an email. “If anyone is found to be guilty of manipulations thereby leading to deliberate scientific fraud, the person will face suitable disciplinary action.”

A handful of the papers have been retracted or corrected by journals, The Hindu notes. CSIR-CDRI’s Naibedya Chattopadhyay, who has had one paper retracted and four ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies